Personal Cfo Solutions, LLC Bristol Myers Squibb CO Transaction History

Personal Cfo Solutions, LLC

  • $704 Million
  • Q3 2024

A detailed history of Personal Cfo Solutions, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 22,583 shares of BMY stock, worth $1.3 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
22,583
Previous 28,482 20.71%
Holding current value
$1.3 Million
Previous $1.18 Million 1.18%
% of portfolio
0.17%
Previous 0.19%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$39.66 - $51.75 $233,954 - $305,273
-5,899 Reduced 20.71%
22,583 $1.17 Million
Q2 2024

Aug 09, 2024
BUY
$40.25 - $52.99 $270,922 - $356,675
6,731 Added 30.95%
28,482 $1.18 Million
Q1 2024

May 13, 2024
BUY
$47.98 - $54.4 $26,532 - $30,083
553 Added 2.61%
21,751 $1.18 Million
Q4 2023

Feb 13, 2024
BUY
$48.48 - $57.85 $339,650 - $405,297
7,006 Added 49.37%
21,198 $1.09 Million
Q3 2023

Nov 13, 2023
BUY
$57.89 - $64.73 $19,798 - $22,137
342 Added 2.47%
14,192 $823,000
Q2 2023

Aug 10, 2023
SELL
$63.71 - $70.74 $25,675 - $28,508
-403 Reduced 2.83%
13,850 $885,000
Q1 2023

May 09, 2023
SELL
$65.71 - $74.53 $41,331 - $46,879
-629 Reduced 4.23%
14,253 $987,000
Q4 2022

Feb 14, 2023
BUY
$68.48 - $81.09 $68,069 - $80,603
994 Added 7.16%
14,882 $1.07 Million
Q3 2022

Nov 01, 2022
SELL
$0.13 - $76.84 $94 - $55,862
-727 Reduced 4.97%
13,888 $987,000
Q2 2022

Aug 05, 2022
SELL
$72.62 - $79.98 $108,276 - $119,250
-1,491 Reduced 9.26%
14,615 $1.13 Million
Q1 2022

May 02, 2022
SELL
$61.48 - $73.72 $110,233 - $132,179
-1,793 Reduced 10.02%
16,106 $1.18 Million
Q4 2021

Feb 11, 2022
SELL
$53.63 - $62.52 $250,023 - $291,468
-4,662 Reduced 20.66%
17,899 $1.12 Million
Q3 2021

Nov 18, 2021
BUY
$59.17 - $69.31 $308,867 - $361,798
5,220 Added 30.1%
22,561 $1.34 Million
Q2 2021

Jul 22, 2021
BUY
$61.91 - $67.42 $10,710 - $11,663
173 Added 1.01%
17,341 $1.16 Million
Q1 2021

Apr 21, 2021
BUY
$59.34 - $66.74 $39,045 - $43,914
658 Added 3.99%
17,168 $1.08 Million
Q4 2020

Feb 09, 2021
BUY
$57.74 - $65.43 $68,479 - $77,599
1,186 Added 7.74%
16,510 $1.02 Million
Q3 2020

Nov 02, 2020
BUY
$57.43 - $63.64 $90,739 - $100,551
1,580 Added 11.5%
15,324 $1,000
Q2 2020

Aug 03, 2020
SELL
$54.82 - $64.09 $231,175 - $270,267
-4,217 Reduced 23.48%
13,744 $808,000
Q1 2020

Apr 30, 2020
SELL
$46.4 - $67.43 $558,099 - $811,048
-12,028 Reduced 40.11%
17,961 $1 Million
Q4 2019

Feb 13, 2020
SELL
$49.21 - $64.19 $212,439 - $277,108
-4,317 Reduced 12.58%
29,989 $1.92 Million
Q3 2019

Nov 13, 2019
BUY
$42.77 - $50.71 $1.47 Million - $1.74 Million
34,306 New
34,306 $1.74 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Personal Cfo Solutions, LLC Portfolio

Follow Personal Cfo Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email